edetic acid has been researched along with Cancer of Ovary in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 8 (44.44) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gajek, A; Marczak, A; Rogalska, A | 1 |
| Eckstein, R; Ringwald, J; Zimmermann, R | 1 |
| Bazou, D; Medina, C; Radomski, MW; Santos-Martinez, MJ | 1 |
| Havsteen, H; Nielsen, LE; Nielsen, SS; Petersen, LK; Rehling, M | 1 |
| Alfonso-De Matte, MY; Kruk, PA | 1 |
| Coleman, RL; Dalgarno, DC; Gallick, GE; Gershenson, DM; Halder, J; Han, LY; Kamat, AA; Kim, TJ; Landen, CN; Lin, YG; Merritt, WM; Metcalf, CA; Sawyer, TK; Shakespeare, WC; Sood, AK; Sundaramoorth, R; Trevino, JG; Wang, Y | 1 |
| Cornelisse, CJ; Corver, WE; Fleuren, GJ; Hermans, J | 1 |
| Maier, RH; Nicholson, DL; Pories, WJ; Purser, SM | 1 |
| Cheung, L; Gano, J; Kavanagh, JJ; Kudelka, AP; Murray, JL; Rosenblum, MG; Verschraegen, CF | 1 |
| Kosaka, Y; Kumagai, S; Ryo, R; Saigo, K; Sugimoto, T; Takeuchi, S | 1 |
| Aird, RE; Chen, H; Cummings, J; Jodrell, DI; Morris, RE; Muir, M; Ritchie, AA; Sadler, PJ | 1 |
| Houle, S; Law, J; Lee, N; Marks, A; Reilly, R | 1 |
| Andersen, LS; Jakobsen, A; Jakobsen, P; Nielsen, JT; Strömgren, A; Sørensen, BT | 1 |
| Fujii, T; Okamoto, K; Sakura, H | 1 |
| Kato, H; Maeda, H; Matsumura, Y | 1 |
| Gilley-Pietsch, C; Heuser, LS; Miller, FN | 1 |
| Chen, X; Li, T; Lu, JJ; Wang, YT; Wu, GS; Xu, XH; Zhang, LL | 1 |
| Cham, BE; Daunter, B | 1 |
1 trial(s) available for edetic acid and Cancer of Ovary
| Article | Year |
|---|---|
Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Ascites; Ascitic Fluid; Bone and Bones; Bone Marrow; Bone Marrow Diseases; Carcinoma; Chelating Agents; Chelation Therapy; Dose-Response Relationship, Immunologic; Dose-Response Relationship, Radiation; Edetic Acid; Fallopian Tube Neoplasms; Female; Glycoproteins; Half-Life; Humans; Injections, Intraperitoneal; Mice; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Peritoneal Neoplasms; Radiation Injuries; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Tissue Distribution; Treatment Outcome; Ytterbium | 1999 |
17 other study(ies) available for edetic acid and Cancer of Ovary
| Article | Year |
|---|---|
Epothilone B induces extrinsic pathway of apoptosis in human SKOV-3 ovarian cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Calcium; Caspases; Cell Line, Tumor; Cytochromes c; DNA Damage; Edetic Acid; Epothilones; Female; Gene Expression Regulation; Humans; Ovarian Neoplasms; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Trypsin | 2014 |
EDTA plasma is unsuitable for in vivo determinations of platelet-derived angiogenic cytokines.
Topics: Angiogenic Proteins; Anticoagulants; Biomarkers, Tumor; Blood Platelets; Blood Specimen Collection; Cytokines; Edetic Acid; Enzyme-Linked Immunosorbent Assay; Female; Humans; Neovascularization, Pathologic; Ovarian Neoplasms; Reproducibility of Results | 2009 |
Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap.
Topics: Actins; Adenocarcinoma; Apyrase; Blood Platelets; Cell Communication; Cell Line, Tumor; Down-Regulation; Edetic Acid; Epoprostenol; Female; Fibrosarcoma; Flow Cytometry; Humans; Matrix Metalloproteinase 2; Microscopy, Confocal; Microscopy, Fluorescence; Ovarian Neoplasms; P-Selectin; Phenanthrolines; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tumor Cells, Cultured; Ultrasonics; Ultrasonography | 2011 |
Patients with ovarian cancer have elevated (51)Cr-EDTA plasma clearance early post-operatively.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascites; Blood Specimen Collection; Carboplatin; Chromium Radioisotopes; Edetic Acid; Female; Glomerular Filtration Rate; Humans; Metabolic Clearance Rate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Postoperative Period; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Statistics as Topic | 2002 |
Phosphatidylinositol triphosphate kinase-dependent and c-jun NH2-terminal kinase-dependent induction of telomerase by calcium requires Pyk2.
Topics: Anisomycin; Calcium; Cell Line; Chromones; DNA-Binding Proteins; Edetic Acid; Enzyme Induction; Enzyme Inhibitors; Epithelial Cells; Female; Focal Adhesion Kinase 2; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Morpholines; Ovarian Neoplasms; Ovary; Phosphatidylinositol 3-Kinases; Protein-Tyrosine Kinases; Recombinant Proteins; Telomerase; Transfection; Tumor Cells, Cultured | 2004 |
Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinoma.
Topics: Adenosine Triphosphate; Angiogenesis Inhibitors; Antineoplastic Agents; Cell Division; Cell Line, Tumor; Edetic Acid; Female; Humans; Ovarian Neoplasms; src-Family Kinases | 2006 |
Limited loss of nine tumor-associated surface antigenic determinants after tryptic cell dissociation.
Topics: Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, CD; Antigens, Tumor-Associated, Carbohydrate; Carrier Proteins; CD47 Antigen; Cell Separation; Edetic Acid; Female; Flow Cytometry; Folate Receptors, GPI-Anchored; Humans; Intercellular Adhesion Molecule-1; Ovarian Neoplasms; Receptors, Cell Surface; Trypsin; Tumor Cells, Cultured | 1995 |
The cytotoxic interaction of inorganic trace elements with EDTA and cisplatin in sensitive and resistant human ovarian cancer cells.
Topics: Antineoplastic Agents; Calcium; Cell Death; Chelating Agents; Cisplatin; Drug Resistance, Neoplasm; Edetic Acid; Female; Humans; Magnesium; Ovarian Neoplasms; Trace Elements; Tumor Cells, Cultured | 1997 |
Estimation of stem cell fractions in peripheral blood stem cell harvest by using an SE-9000 hematology analyzer.
Topics: Anticoagulants; Antigens, CD34; Automation; Blood Cell Count; Breast Neoplasms; Chelating Agents; Edetic Acid; Equipment Design; Evaluation Studies as Topic; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Indicators and Reagents; Leukapheresis; Ovarian Neoplasms; Surface-Active Agents | 2000 |
In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azacitidine; Calcium Channel Blockers; Carboplatin; Cisplatin; Decitabine; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Edetic Acid; Female; Humans; Ligands; Mice; Mice, Nude; Neoplasm Proteins; Organometallic Compounds; Ovarian Neoplasms; Ruthenium Compounds; Structure-Activity Relationship; Verapamil; Xenograft Model Antitumor Assays | 2002 |
In vitro stability of EDTA and DTPA immunoconjugates of monoclonal antibody 2G3 labeled with indium-111.
Topics: Antibodies, Monoclonal; Ascitic Fluid; Drug Stability; Edetic Acid; Female; Humans; In Vitro Techniques; Indium Radioisotopes; Isotope Labeling; Ovarian Neoplasms; Pentetic Acid | 1992 |
Renal handling of carboplatin.
Topics: Adult; Aged; Carboplatin; Chromium Radioisotopes; Edetic Acid; Female; Humans; Kidney; Middle Aged; Ovarian Neoplasms; Time Factors | 1992 |
A study of human calcitonin in an ovarian carcinoid and ovarian cancers.
Topics: Aprotinin; Benzamidines; Biomarkers, Tumor; Calcitonin; Carcinoid Tumor; Chromatography, Gel; Edetic Acid; Female; Gabexate; Guanidines; Humans; Ovarian Neoplasms; Pepstatins; Prostaglandins E; Radioimmunoassay; Struma Ovarii | 1991 |
Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC.
Topics: Amino Acid Sequence; Angiotensin-Converting Enzyme Inhibitors; Ascitic Fluid; Bradykinin; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Edetic Acid; Female; Humans; Kinins; Liver Neoplasms; Lysine Carboxypeptidase; Molecular Sequence Data; Ovarian Neoplasms; Peptide Fragments; Peptide Hydrolases; Peptidyl-Dipeptidase A; Protease Inhibitors | 1990 |
Protein leak from normal vasculature due to human malignant ascites.
Topics: Adenocarcinoma; Animals; Ascites; Ascitic Fluid; Blood Proteins; Capillary Permeability; Edetic Acid; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Humans; Hydrogen-Ion Concentration; Isotonic Solutions; Male; Microcirculation; Microscopy, Fluorescence; Ovarian Neoplasms; Peritoneum; Plasma; Rats; Rats, Inbred Strains; Thiocyanates | 1988 |
Solasodine Induces Apoptosis, Affects Autophagy, and Attenuates Metastasis in Ovarian Cancer Cells.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Female; Humans; Membrane Potential, Mitochondrial; Neoplasm Invasiveness; Neoplasm Metastasis; Ovarian Neoplasms; Solanaceous Alkaloids | 2017 |
Solasodine glycosides. In vitro preferential cytotoxicity for human cancer cells.
Topics: Carbohydrate Sequence; Carbohydrates; Cell Survival; Dose-Response Relationship, Drug; Female; Fibroblasts; Glycosides; HeLa Cells; Humans; Lectins; Lethal Dose 50; Lymphocyte Activation; Lymphocytes; Molecular Sequence Data; Ovarian Neoplasms; Solanaceous Alkaloids; Thymidine; Tritium; Tumor Cells, Cultured | 1990 |